Drugs / PRO-067
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02801617 | Sep 2015 → Mar 2017 | ocular hypertension, open-angle glaucoma | Laboratorios Sophia S.A de C.V. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-067 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02801617 ↗ |
| Route | Other | “PRO-067 ophthalmic solution” NCT02801617 ↗ |